Ignite Creation Date:
2025-12-25 @ 2:09 AM
Ignite Modification Date:
2026-01-07 @ 5:56 PM
Study NCT ID:
NCT00466960
Status:
COMPLETED
Last Update Posted:
2017-08-28
First Post:
2007-04-25
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Sargramostim and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer That Did Not Respond to Previous Chemotherapy
Sponsor:
University of Washington
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2006-05
Start Date Type:
None
Primary Completion Date:
2011-07
Primary Completion Date Type:
ACTUAL
Completion Date:
None
Completion Date Type:
None
First Submit Date:
2007-04-25
First Submit QC Date:
None
Study First Post Date:
2007-04-27
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2017-04-17
Results First Submit QC Date:
None
Results First Post Date:
2017-08-28
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-07-24
Last Update Post Date:
2017-08-28
Last Update Post Date Type:
ACTUAL